Wednesday, February 10, 2010, 6:52am EST - Canadian Markets open in 2 hours and 38 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

InterMune Inc. (ITMN)

 On Feb 9: 15.60 USD   0.00 (0.00%)  
MORE ON ITMN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
InterMune, Inc. (NasdaqNM:ITMN) Delayed quote dataEdit
Last Trade: 15.60 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 15.60
Open: N/A
Bid: 3.26 x 100
Ask: 29.74 x 100
1y Target Est: 26.37
Day's Range: N/A - N/A
52wk Range: 10.48 - 19.12
Volume: 0
Avg Vol (3m): 748,598
Market Cap: 728.04M
P/E (ttm): N/A
EPS (ttm): -2.48
Div & Yield: N/A (N/A%)
InterMune Inc. (ITMN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add ITMN to Portfolio   Download Data

HEADLINES
• Biotech ETFs Immune To Broad Selling
Investor's Business Daily (Mon, Feb 8)
• Three Stocks The Insiders Love
at Investopedia (Fri, Feb 5)
• [$$] Pericom, PetroQuest, Kulicke & Soffa Jump
at The Wall Street Journal Online (Mon, Feb 1)
• Big Week For Pharma
at CNBC (Mon, Feb 1)
• [video] Take Your Position: Pharma's Big Week
at CNBC (Mon, Feb 1)
• Monday Options Recap
at Seeking Alpha (Mon, Feb 1)
• InterMune call volume pops ahead of FDA panel
at Reuters (Mon, Feb 1)
• InterMune gets March FDA review for lung drug
AP (Mon, Feb 1)
• InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
PRNewswire (Mon, Feb 1)
• Insider Trading Continues to Reflect Weak Recovery
at Seeking Alpha (Mon, Feb 1)
• INTERMUNE INC Files SEC form 8-K, Other Events
EDGAR Online (Fri, Jan 29)
• Deathbed Stocks Revisited
at Motley Fool (Fri, Jan 29)
More Headlines for ITMN...
ANALYST
EPS Est (next year) (Dec-07) : -2.61
EPS Est (in 2 years) (Dec-08) : -2.63
Avg Rec (current)*: 1.9
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
InterMune, Inc., a biotechnology company, focuses on the development and commercialization of therapies in pulmonology and hepatology. It offers Actimmune for the treatment of chronic granulomatous disease and severe, malignant osteopetrosis in th...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices